Skip to main content

Genicon Sciences, BD Biosciences Pen Microarray Collaboration

NEW YORK, Dec. 18 — Genicon Sciences is partnering with BD Biosciences Clontech to adapt its Resonance Light Scattering signal generation and detection technology for BD's microarrays.

 

The agreement, announced on Tuesday, gives Genicon Sciences the right to develop, manufacture, distribute, and promote its system for specific use on the BD Atlas group of microarrays. The system includes reagents, instrumentation, and analysis software.

 

In addition, BD Biosciences Clontech will promote Genicon's integrated assay system.

 

Financial details of the deal were not disclosed.

 

BD Biosciences Clontech, based in Palo Alto, Calif., manufactures pre-spotted glass microarrays containing up to 3,800 human, mouse, and rat DNA oligonucleotides.

 

Genicon Sciences, of San Diego, is a privately held company that focuses on assay technologies and development.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.